Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke by Karoline Möller et al.
ORIGINAL RESEARCH
published: 27 November 2015
doi: 10.3389/fncel.2015.00461
Edited by:
Dirk M. Hermann,
Essen University Hospital, Germany
Reviewed by:
Lei Liu,
University of Florida, USA
Michelle A. Clark,
Nova Southeastern University, USA
*Correspondence:
Daniel-Christoph Wagner
daniel-
christoph.wagner@izi.fraunhofer.de
†These authors have contributed
equally to this work.
Received: 09 September 2015
Accepted: 12 November 2015
Published: 27 November 2015
Citation:
Möller K, Pösel C, Kranz A, Schulz I,
Scheibe J, Didwischus N, Boltze J,
Weise G and Wagner DC (2015)
Arterial Hypertension Aggravates
Innate Immune Responses after
Experimental Stroke.
Front. Cell. Neurosci. 9:461.
doi: 10.3389/fncel.2015.00461
Arterial Hypertension Aggravates
Innate Immune Responses after
Experimental Stroke
Karoline Möller1,2†, Claudia Pösel1†, Alexander Kranz1, Isabell Schulz1,
Johanna Scheibe1, Nadine Didwischus1,3, Johannes Boltze1,4, Gesa Weise1,5 and
Daniel-Christoph Wagner1*
1 Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany, 2 Institute of Anatomy, Histology and Embryology,
University of Leipzig, Leipzig, Germany, 3 Research Group Human Biology, Institute of Biology, University of Leipzig, Leipzig,
Germany, 4 Fraunhofer Research Institution for Marine Biotechnology and Institute for Medical and Marine Biotechnology,
University of Lübeck, Lübeck, Germany, 5 Department of Neurology, University of Leipzig, Leipzig, Germany
Arterial hypertension is not only the leading risk factor for stroke, but also attributes to
impaired recovery and poor outcome. The latter could be explained by hypertensive
vascular remodeling that aggravates perfusion deficits and blood–brain barrier
disruption. However, besides vascular changes, one could hypothesize that activation
of the immune system due to pre-existing hypertension may negatively influence post-
stroke inflammation and thus stroke outcome. To test this hypothesis, male adult
spontaneously hypertensive rats (SHRs) and normotensive Wistar Kyoto rats (WKYs)
were subjected to photothrombotic stroke. One and 3 days after stroke, infarct
volume and functional deficits were evaluated by magnetic resonance imaging and
behavioral tests. Expression levels of adhesion molecules and chemokines along with
the post-stroke inflammatory response were analyzed by flow cytometry, quantitative
real-time PCR and immunohistochemistry in rat brains 4 days after stroke. Although
comparable at day 1, lesion volumes were significantly larger in SHR at day 3. The
infarct volume showed a strong correlation with the amount of CD45 highly positive
leukocytes present in the ischemic hemispheres. Functional deficits were comparable
between SHR and WKY. Brain endothelial expression of intercellular adhesion molecule
1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and P-selectin (CD62P)
was neither increased by hypertension nor by stroke. However, in SHR, brain
infiltrating myeloid leukocytes showed significantly higher surface expression of ICAM-
1 which may augment leukocyte transmigration by leukocyte–leukocyte interactions.
The expression of chemokines that primarily attract monocytes and granulocytes
was significantly increased by stroke and, furthermore, by hypertension. Accordingly,
ischemic hemispheres of SHR contain considerably higher numbers of monocytes,
macrophages and granulocytes. Exacerbated brain inflammation in SHR may finally
be responsible for larger infarct volumes. These findings provide an immunological
explanation for the epidemiological observation that existing hypertension negatively
affects stroke outcome and mortality.
Keywords: stroke, hypertension, animal model, inflammation, neutrophils, macrophages, adhesion molecules,
chemokines
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INTRODUCTION
About one-third of the world population suﬀers from arterial
hypertension, deﬁned by blood pressure values higher than
140/90 mmHg (James et al., 2014). Among all organs, the
brain is most susceptible to increased blood pressure. Without
perceptible symptoms, hypertension successively remodels the
brain microvasculature, ultimately causing parenchymal damage,
cognitive impairment and dementia (Pantoni, 2010). Moreover,
hypertension-related sclerosis of extra- and intracerebral arteries
is a leading cause for stroke, whereas existing hypertension
correlates with worse outcome and increased mortality after
stroke (Willmot et al., 2004; O’Donnell et al., 2010). A disturbed
autoregulatory capacity of brain vessels, endothelial oxidative
stress, and focal hypertensive blood–brain barrier damage may
contribute to increased brain injury after stroke (Faraco and
Iadecola, 2013). However, the role and impact of the immune
system in this pathophysiological cascade is poorly understood.
It is well-recognized though that hypertension and
hypertensive brain damage are determined and maintained
by a plethora of inﬂammatory processes. Increased blood
pressure causes an activation of brain-resident astrocytes and
microglia and an upregulation of adhesion molecule (AM)
expression on brain endothelial cells (Gouw et al., 2011; Wardlaw
et al., 2013; Kaiser et al., 2014). In the periphery, hypertension
correlates with monocyte activation (Dorﬀel et al., 1999; Ishibashi
et al., 2004) and increased plasma levels of pro-inﬂammatory
cytokines (Kim et al., 2008). Autonomic dysfunction during
hypertension (Mancia and Grassi, 2014) promotes myelopoiesis
and leukocyte activation in secondary lymphatic organs (Ganta
et al., 2005; Harwani et al., 2012; Zubcevic et al., 2014). Chronic
hypertension thus perpetuates a state of inﬂammation and
immune activation that may aﬀect severity and progression of
acute stroke.
In fact, stroke itself is characterized by a sterile tissue
inﬂammation initiated by damage-associated molecular patterns
and cytokine release (Shichita et al., 2012b). In the acute phase,
post-stroke inﬂammation is dominated by innate immune cells,
namely polymorphonuclear neutrophils (PMNs), monocytes,
macrophages and microglia (Gelderblom et al., 2009; Benakis
et al., 2014; Moller et al., 2014). Importantly, it has been
shown that less PMN inﬁltration and the correct as well as
timely resolution of inﬂammation by macrophages are important
indicators for better stroke outcome (Gliem et al., 2012;
Neumann et al., 2015).
We hypothesized that the aforementioned immunological
sequelae of existing hypertension could dysregulate and
exacerbate the immune response to stroke and thus aﬀect
the overall outcome. To investigate this hypothesis, we
compared stroke development, cerebral AM expression and
neuroinﬂammation in spontaneously hypertensive rats (SHRs)
and normotensive Wistar Kyoto rats (WKYs). Due to cerebral
microangiopathy and impaired cerebral blood ﬂow regulation,
traditional stroke models such as transient or permanent
middle cerebral artery occlusion (MCAO) generally cause larger
infarcts in hypertensive rats (Hom et al., 2007; De Geyter et al.,
2012; Kang et al., 2014). This would, however, confound the
investigation of secondary immune-related changes. To dissect
the eﬀect of hypertension on post-stroke inﬂammation we
hence decided to use the photothrombotic stroke (PT) model
(Watson et al., 1985), that allows generating an ischemic lesion
independent of the status of the cerebrovascular system. In fact,
we found that SHR and WKY exhibit comparable lesion volumes
at 24 h after stroke. However, 2 days later, infarct volumes were
signiﬁcantly larger in SHR, possibly as consequence of increased
amounts of myeloid innate immune cells that inﬁltrated into the
ischemic brain. Our ﬁndings therefore oﬀer an immunological
explanation for the epidemiologically established fact that arterial
hypertension negatively aﬀects stroke outcome and mortality.
MATERIALS AND METHODS
Animals and Group Allocation
All animal experiments were carried out according to the Guide
for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No.
85-23, revised 1996) and approved by the appropriate federal
authority. SHR and WKY (Charles River, Sulzfeld, Germany) at
the age of 12–14 weeks were randomly assigned to the following
experimental groups: (1) naive WKY (n = 10); (2) naive SHR
(n = 10); (3) WKY with stroke (n = 18); (4) SHR with stroke
(n = 22). Group 4 was planned with additional four animals to
compensate for a potentially increased stroke-related mortality
in hypertensives. Animals were randomly assigned to subgroup
analyses as speciﬁed in the according methods sections. Health
status and body weight was monitored twice a day during the
experiment. Exclusion criteria were: (i) weight loss of more than
20%; deterioration of the health status that requires supportive
action; (ii) absence of a cortical lesion typical for the stroke model
used; (iii) massive brain hemorrhage.
Experimental Stroke Model
Photothrombotic stroke was induced in groups 3 and 4 as
described previously (Diederich et al., 2014). Brieﬂy, rats
were anesthetized with 2% isoﬂurane in 100% oxygen. Body
temperature was maintained at 36.5 ± 0.5◦C by a feedback-
controlled heating device. PT was induced in the right frontal
cortex. For illumination, a ﬁber-optic bundle of a cold light
source (4.5 mm diameter) was centered stereotactically 1 mm
posterior and 2.5 mm lateral from Bregma on the intact skull.
Afterward, 0.3 mL of a sterile-ﬁltered Rose Bengal solution
(Sigma, Germany) was injected into the tail vein and the brain
was illuminated for 20 min. After surgery, the skin was sutured
and animals were placed in heated cages for recovery.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) investigations were
performed at a 7 Tesla (T) PharmaScan 70/16 (Bruker Biospin,
Germany). The system with a gradient strength of 375 mT/m
was equipped with a transmit-only volume coil for excitation
and a receive-only rat brain array coil for detection (Bruker
Biospin, Ettlingen, Germany). All data were acquired with
Topspin 2.0 and Paravision 5.1 software (Bruker BioSpin).
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Animals were anesthetized with 2% isoﬂurane in 100%
oxygen. Body temperature was monitored via a rectal probe
and maintained at 37.0 ± 0.5◦C. The region of interest was
localized using a standard gradient echo FLASH survey scan
(Tripilot, Bruker). For acquisition of 22 axial slices, a spin
echo multislice rapid acquisition and relaxation enhancement
(RARE) technique was applied with the following parameters:
repetition time (TR) = 3440 ms, echo time (TE) = 48.8 ms,
matrix size (512 × 512), ﬁeld of view = (27.5 × 27.5) mm2, slice
thickness = 0.8 mm, slice gap = 0.2 mm. The corresponding
voxel size was 0.05 mm × 0.05 mm × 0.8 mm. The total
acquisition time was 18 min. Two measurements (day 1, n = 4/5;
day 3, n = 8/9) were acquired, exported as DICOM ﬁles and
processed with ImageJ (NIH, Bethesda, MD, USA). The area of
the ischemic lesion (LV), the ipsilateral (SVi) and contralateral
(SVc) side ventricles and both hemispheres (HVi and HVc)
were manually segmented using anatomical landmarks and
T2 hyperintense structures by an investigator blinded for the
group allocation. These parameters were used to calculate the
lesion volume and the space occupying eﬀect due to brain edema
(%HSE) as described previously (Gerriets et al., 2004).
Behavioral Tests
Behavioral tests were carried out 1 and 3 days after stroke onset
at the beginning of the dark phase (6:00 pm) by an investigator
blinded to the group allocation (n = 7/10). The assessment of
the modiﬁed neurological severity (mNS) score was performed as
described previously (Chen et al., 2001). For the adhesive removal
test (ART), adhesive labels of 64 mm2 were stuck on the ipsi- and
contralateral palm of the forepaw. The time needed to remove
the labels was assessed in technical duplicates and converted into
the asymmetry score using the following formula: (removal time
ipsilateral – removal time contralateral)/(removal time ipsilateral
+ removal time contralateral; Minnerup et al., 2011). Animals
were adapted to the ART setting for 3 days prior to the start of
the experiment.
Sampling
At day 4 after stroke, rats were sacriﬁced by CO2 exposition
subsequent to deep inhalation anesthesia (5% isoﬂurane in
100% oxygen). After opening of the thoracic cavity, 1 mL of
anticoagulated blood was withdrawn from the left ventricle and
collected in 2 mM EDTA. For ﬂow cytometry or quantitative
real-time PCR, rats were transcardially perfused with 200 mL
of ice-cold PBS. Rats that were allocated to histological analyses
were additionally perfused with 200 mL of ice-cold 4% formalin
solution.
Analysis of Peripheral Blood Leukocytes
Absolute counts of PMNs and monocytes were determined by an
animal blood counter (scil Vet abc, SCIL animal care company
GmbH, Viernheim, Germany; n= 4/4/7/10). To determine CD43
expression on monocyte subsets, 50 μl EDTA-blood was diluted
in 50 μl phosphate buﬀered saline (PBS) and incubated with
a mixture of the following monoclonal antibodies: CD43-Alexa
Fluor 647 (clone W3/13, Biolegend, San Diego, CA, USA), CD45-
APC-Cy7 (OX1, BD Biosciences, Heidelberg, Germany), CD11b-
Paciﬁc Blue (MRC-OX42, Abd Serotec, Oxford, UK) for 20 min
at 4◦C. Erythroid cells were lysed by short-term incubation with
distilled water followed by repeated washing with FC buﬀer
(PBS containing 3% fetal calf serum). Remaining leukocytes were
resuspended in 300 μL FC buﬀer. Flow cytometric acquisition
and analysis were performed using a 3-laser FACSCanto II
equipped with the FACSDiva software (BD Biosciences) by an
investigator blinded to the group allocation.
Quantitative Real-time PCR
Brains hemispheres were removed (n = 3/3/3/3), separated
and manually dissociated using razor blades. Total RNA of
100 mg tissue was extracted by homogenization in 1 mL
Trizol using a ULTRA-TURRAX (Ika, Staufen, Germany)
and further puriﬁed by RNeasy Mini Kit (Qiagen, Hilden,
Germany). Single-strand cDNA copies were generated from 5 μg
of puriﬁed total RNA by using Oligo(dT) 15 primers (Promega,
Mannheim, Germany) and Superscript III reverse transcriptase
(Invitrogen/Life Technologies, Darmstadt, Germany) according
to manufacturer’s instructions. Quantiﬁcation of mRNA
expression was performed and monitored using an ABI
7900 real-time PCR system (Applied Biosystems, Darmstadt,
Germany) applying the following conditions: initial denaturation
at 95◦C for 10 min, followed by 50 cycles at 95◦C for 15 s
and 55◦C for 1 min. All qRT-PCR reactions were conducted
in a total volume of 10 μL with addition of QuantiTect SYBR
Green (Qiagen) and gene speciﬁc QuantiTect primers (Qiagen):
VCAM-1 (QT00178500), ICAM-1 (QT00174447), CD62P
(QT00180418), CCL2 (QT00183253), CCL3 (QT00378350),
CCL4 (QT00187075), CCL7 (QT01593767), CXCL2
(QT00184891), CXCL5 (QT00392777), IL1-β (QT00181657),
IL-6 (QT00182896), TNF-α (QT00178717), IL-10 (QT00177618)
MMP9 (QT00178290) TGF-β (QT00187320). Data were analyzed
using the relative standard curve method and normalized to
the average cycle threshold of the housekeeping genes B2M
(QT00176295), RPL13a (QT00425873), rpl22 (QT00385119),
Yhwaz (QT02382184).
Histology
Perfusion-ﬁxed brains were removed, kept in 4% formalin
solution for 24 h and treated with 30% sucrose solution for
3 days (n = 3/3/3/3). Subsequently, brains were shock-frozen
and stored at −80◦C until further use. Frozen brains were
cut into 20 μm coronal slices and mounted on Superfrost
Plus slides (Carl Roth, Karlsruhe, Germany). Next, brain
slices were incubated in blocking buﬀer (5% goat serum,
0.3% Triton X-100 and PBS) for 2 h, followed by incubation
with combinations of rabbit anti-glial ﬁbrillary acidic protein
(GFAP, 1:500, DAKO, Hamburg, Germany), rabbit anti-ionized
calcium binding adaptor molecule 1 (Iba1, 1:200, Wako, Neuss,
Germany), mouse anti-intercellular adhesion molecule 1 (ICAM-
1/CD54, 1:200, Hölzel Diagnostika, Cologne, Germany), mouse
anti- P-selectin (CD62P, 1:200, Novus Biologicals, Cambridge,
UK) and biotinylated solanum tuberosum lectin (STL, 1:300,
Linaris, Dossenheim, Germany) overnight at 4◦C. Sections were
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then incubated with the according combinations of goat anti-
mouse Alexa Fluor 488, goat anti-mouse Alexa Fluor 546, goat
anti-rabbit Alexa Fluor 488, goat anti-rabbit Alexa Fluor 546
(all 1:400, Invitrogen, Darmstadt, Germany) and streptavidin
(1:1000, Dianova, Hamburg, Germany) conjugated with Cy5
for 2 h at room temperature. All sections were counter-
stained with 4′, 6-diamidin-2-phenylindol (DAPI; Sigma) using
a concentration of 1 μg/mL for 10 min. As negative control,
according brain slices were processed analogously except the use
of the primary antibody. Fluorescence image stacks were acquired
with a Zeiss (Göttingen, Germany) LSM710 confocal laser
scanning microscope (Laser: Diode 405, Argon 488, Helium-
Neon 543; Objective: Plan- Apochromat 63x/1.40 oil) and saved
using a compression free image format. Image stacks were
presented as maximum intensity projection or as orthogonal slice
view.
Flow Cytometric Analysis of Brain
Endothelial Cells and Leukocytes
After transcardial perfusion with 200 mL of ice-cold PBS,
brains were removed and separated from the cerebellum
and olfactory bulb (n = 3/3/7/10). Brain hemispheres were
hemisected and mechanically dissected using razor blades.
Single cell suspensions of the ischemic and contralateral brain
hemispheres were obtained by intermittent enzymatic digestion
with collagenase I (Sigma, Munich, Germany) and DNAse I
(Roche, Mannheim, Germany) in Hanks balanced salt solution
(HBSS) for 45 min at 37◦C, including two trituration steps
using a gentleMACS Dissociator (Miltenyi Biotec., Bergisch
Gladbach, Germany). Immune cells were then separated by
density gradient centrifugation on discontinuous Percoll (GE
Healthcare, München, Germany) gradients composed of four
sequent layers (80%/38%/21% Percoll covered with cell culture
medium). Cells accumulating in between 80%/38% Percoll were
harvested and washed. Finally, cells were resuspended in 100 μL
FC buﬀer and cell counts and viability were determined by
trypan blue exclusion in a hemocytometer. Total cell suspensions
were subsequently incubated with a speciﬁc FC-blocking reagent
(puriﬁed anti-rat CD32; BD Bioscience) for 10 min at 4◦C
and labeled with the following anti-rat antibodies for 20 min
at 4◦C: CD163-FITC (clone ED2, Abd Serotec), CD62P-Alexa
Fluor 488 (Psel.KO.2.12, Abd Serotec), Granulocytes-PE (RP1,
BD Biosciences), CD3-PE (1F4, Biolegend), RT1B-PerCP (OX6,
BD Biosciences), VCAM-1-PE (MR106, Abd Serotec), CD80-
Biotin (3H5, Ebioscience, San Diego, CA, USA), ICAM-1 PerCP-
eFluor 710 (1A29, Ebioscience), CD31-eFluor 660 (TLD-3A12,
Ebioscience), CD45-APC-Cy7 (OX1, BD Biosciences), CD11b-
Paciﬁc Blue (MRC-OX42, Abd Serotec). Biotinylated CD80 was
secondly labeled with streptavidin-PE-Cy7 (Ebioscience) for
additional 15 min at 4◦C in the dark. After ﬁnal washing,
cell suspensions were resuspended in 200 μL FC buﬀer and
stored at 4◦C until further use. Flow cytometric acquisition was
performed as described above by an investigator blinded to the
group allocation. Absolute numbers of brain immune cells were
determined by additional Trucount Tube measurements (BD
Biosciences). The median ﬂuorescence intensity (MFI) of the
AMs ICAM-1, VCAM-1, or CD62P was corrected by subtraction
of the population speciﬁc median autoﬂuorescence intensity.
Statistics
Data were presented as mean (M) ± standard deviation (SD).
Two experimental groups were compared by unpaired t-tests.
Data from more than two groups were analyzed by one-way
ANOVA followed by Newman–Keuls multiple comparison test.
Functional data were analyzed by two-way repeated measures
ANOVA followed by Bonferroni’s post hoc test. Correlation
was determined by Pearson’s correlation coeﬃcient analysis. P
values of<0.05 were considered statistically signiﬁcant. Statistical
analyses were performed using GraphPad Prism 5.03.
RESULTS
Exclusions
Two SHR and one WKY were excluded from the study due to
the absence of an ischemic lesion. Two WKY and one SHR died
during the MR measurement. Another SHR was excluded solely
from the behavioral tests due to a lack of compliance. Owing to
technical problems the brain of one SHR could not be processed
for ﬂow cytometry, and the brains of two SHR and one WKY
could not be analyzed for the expression of AMs.
Impact of Hypertension on Infarct
Volume and Functional Deficits
We ﬁrst determined the impact of pre-existing hypertension
on photothrombotic lesion development by MR imaging. All
animals that met the inclusion criteria exhibited a hyperintense
lesion within the right cortex. The calculation of the space-
occupying eﬀect revealed no diﬀerences between SHR and WKY
at days 1 (6.8± 5.4 %HSE versus 5.9± 3.7 %HSE, p= 0.78) and 3
(5.4± 3.0 versus 4.9± 3.4, p= 0.75) after PT. The infarct volume
was also comparable at day 1, but signiﬁcantly less decreased
in SHR 3 days after PT (Figure 1A). Pearson’s correlation test
showed a strong relation between the infarct volume at day 3
and the amount of CD45 highly positive leukocytes within the
ischemic hemisphere at day 4 (Figure 1B). Next, we investigated
whether hypertension also aﬀects functional outcome in the acute
phase after stroke by means of the ART and the mNS scoring
system. Both tests revealed a neurological deﬁcit after stroke, but
no signiﬁcant diﬀerences between SHR and WKY (Figure 1C).
Impact of Hypertension and Stroke on
Circulating Immune Cells
Hematological analyses showed increased levels of circulating
polymorphonuclear granulocytes (PMN) and monocytes already
in naive SHR. PT had no statistically signiﬁcant impact
on circulating PMN or monocyte counts (Figure 1D). We
next determined the impact of hypertension and stroke on
the percentages of classical and non-classical monocytes by
ﬂow cytometric analysis of CD43 expression. CD43+ non-
classical monocytes in rats correspond to Ly6C low/CX3CR1
high monocytes in mice whereas CD43- classical monocytes
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FIGURE 1 | Infarct volume, neurological deficits and myeloid blood cell counts after photothrombotic stroke (PT) in spontaneously hypertensive rats
(SHRs) and Wistar Kyoto rats (WKYs). (A) The infarct volume was determined by magnetic resonance (MR) imaging at days 1 and 3 after PT (n = 4/5/8/9).
Images show representative series of MR images 3 days after PT in WKY and SHR. (B) Pearson’s correlation of the infarct volume and the amount of CD45 highly
positive cells within the ischemic hemisphere (n = 8/9). (C) Neurological deficits were assessed 1 day before, and at days 1 and 3 after PT using the adhesive
removal test (ART) asymmetry score (AS) and the modified neurological severity (mNS) score (n = 5/8). (D) Quantification of circulating polymorphonuclear
granulocytes (PMN) and monocytes in peripheral blood samples (n = 4/4/5/9). Data are mean values ± standard deviation. ∗p < 0.05, ∗∗p < 0.01.
resemble Ly6C high/CCR2 high monocytes (Strauss-Ayali et al.,
2007). Naive SHR showed a signiﬁcantly higher proportion of
CD43+ non-classical monocytes compared to WKY (M ± SD:
88.8 ± 7.8% versus 76.8 ± 3.1%, p< 0.05, n = 4/4). This relation
was similar after PT (M ± SD: 85.8 ± 3.9% versus 77.9 ± 3.8%,
p < 0.01, n = 5/9), indicating that circulating monocyte subsets
were altered by arterial hypertension, but not by stroke.
Cerebral AM Expression is Altered by
Hypertension and Stroke
Adhesion molecules are crucial for the recruitment of leukocytes
into the ischemic lesion. We therefore aimed to investigate
whether hypertension and stroke inﬂuences the expression of
AMs in the brain. qRT-PCR of whole hemispheric lysates
revealed comparable mRNA expression of VCAM-1 in naive
and stroked SHR and WKY (Figure 2A). The expression
of ICAM-1 mRNA was also comparable in naive SHR and
WKY. PT caused a signiﬁcantly increased ICAM-1 expression
in both rat strains, but this eﬀect was signiﬁcantly higher in
SHR (Figure 2B). Immunoﬂuorescence staining showed that
ICAM-1 was expressed in small capillaries throughout the
ipsi- and contralateral hemisphere (Figure 2C) and within
the parenchymal basement membrane of post-capillary venules
adjacent to the ischemic lesion (Figure 2D). Interestingly, we
also found ICAM-1 expression on round, Iba1+ leukocytes
within the ischemic lesion (Figure 2E) and rarely within
the lesion border (not shown). Together, these observations
indicate that the increased expression of ICAM-1 mRNA in
the ischemic hemisphere primarily derives from the vasculature
and from inﬁltrating leukocytes. PT caused a distinct increase
of P-selectin (CD62P) expression in both SHR and WKY,
a ﬁnding that was not further inﬂuenced by hypertension
(Figure 2F). Immunoﬂuorescence staining revealed strong
CD62P expression on vessels within the ischemic lesion (not
shown). We furthermore observed spotty CD62P expression
without associated nuclei surrounding Iba1+ leukocytes within
the ischemic lesion (Figure 2G), possibly corresponding to
CD62P expressing platelets.
To diﬀerentiate AM expression on cerebral endothelial cells
from inﬁltrated CD45 highly positive (CD45++) leukocytes,
we performed ﬂow cytometry analysis of CD31, CD45, and
CD11b expression in whole hemispheric lysates (Figure 3A).
Analysis of MFIs of ICAM-1, VCAM-1, and CD62P allowed
us to quantify the average expression of these AMs on
brain endothelial cells (CD31+/CD45-) and myeloid leukocytes
(CD31−/CD45++/CD11b+). Neither hypertension nor stroke
had an impact on the endothelial expression of ICAM-1 and
VCAM-1 at day 4 after PT (Figures 3B,C). By contrast, we
found a signiﬁcantly decreased expression of CD62P on brain
endothelial cells of naive SHR, a ﬁnding that was not further
inﬂuenced by stroke (Figure 3D). Leukocyte AM expression
was not inﬂuenced by hypertension in naive rats, but by stroke:
SHR exhibited a signiﬁcantly increased MFI of ICAM-1 on
myeloid leukocytes (Figure 3B), whereas VCAM-1 and CD62P
remained unchanged (Figures 3C,D). Taken together, these
data suggests that the increased ICAM-1 expression on innate
immune cells in SHR may facilitate leukocyte transmigration
by intravascular leukocyte–leukocyte interactions. By contrast,
the brain endothelium of SHR is not increasingly permissive for
transmigrating leukocytes.
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FIGURE 2 | Adhesion molecule expression within the ischemic brain of SHRs and WKYs assessed by quantitative real time PCR and
immunofluorescence. mRNA expression of (A) vascular cell adhesion molecule 1 (VCAM-1) and (B) intercellular adhesion molecule 1 (ICAM-1) mRNA expression.
(C–E) Co-staining of ICAM-1 with Solanum tuberosum lectin (STL), glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba1).
ICAM-1 is co-expressed by STL+ endothelial cells within the ipsi- and contralateral hemisphere (C), within the parenchymal basement membrane of post-capillary
venules adjacent to the ischemic lesion (D) and by Iba1+ myeloid leukocytes within the ischemic lesion (E). mRNA expression of (F) P-selectin (CD62P) and-staining
of CD62P and Iba1 (G). Nuclei were counterstained with DAPI; n = 3/3/3/3, data are mean values ± standard deviation. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Scale bars: (C) 10 μm; (D) 10 and 1.5 μm; (E) 10 μm; (G) 10 μm.
Post-stroke Chemokine Expression in
the Brain is Altered by Hypertension
We next asked whether the stroke-induced expression of
chemokines is also altered by pre-existing hypertension. To
answer this question, we examined mRNA expression of selected
CC and CXC chemokine ligands in whole hemispheric lysates.
Naive SHR and WKY showed comparable levels of CC and
CXC chemokines. However, the expression of CCL2, CCL3,
CCL4, CCL7, and CXCL2 was strongly increased after stroke,
whereas CCL19, CCL20, and CXCL5 expression levels were not
changed (Figure 4). When comparing SHR and WKY subjected
to stroke, we observed a signiﬁcantly higher expression of CCL2,
CCL7, and CXCL2 in SHR. By contrast, CCL3 was signiﬁcantly
decreased in SHR (Figure 4).
Post-stroke Inflammation is Increased in
SHR
To characterize and quantify the inﬂammatory inﬁltrate within
the ischemic brain, we performed ﬂow cytometric analyses of
whole hemispheric lysates. The antibody panel used in this study
allowed us to diﬀerentiate T cells, B cells, PMN, monocytes,
macrophages, and CD11b+ dendritic cells (Figure 5A). None of
the investigated leukocyte subsets diﬀered between naive SHR
and WKY. However, stroke caused a fourfold increase of CD45
highly positive cells that inﬁltrated into the ischemic lesion in
SHR, while we found only a minor, statistically not signiﬁcant
increase in WKY (Figure 5B). T cells, B cells (Figure 5B)
and CD11b+ dendritic cells (not shown) were not altered by
stroke. In contrast, we found that primarily PMN, monocytes,
and macrophages gave rise for the signiﬁcant increase of CD45
high leukocytes in SHR. Each of the three cell populations was
signiﬁcantly increased after stroke in SHR when compared to
naive SHR or WKY with stroke (Figure 5B). The calculation
of the resolution index, the ratio between macrophages and
PMN, allows an estimation of the progress of the clearance
of inﬂammation (Bratton and Henson, 2011). Interestingly,
this index was signiﬁcantly increased in SHR indicating that
the inﬂammation started earlier or was cleared more rapidly
in SHR. Macrophages participating in inﬂammatory processes
can be diﬀerentiated by distinct functional properties with the
M1 and M2 phenotypes being the extremes. Flow cytometric
analysis revealed similar proportions of M1 (CD80+) and M2
(CD163+) macrophages in ischemic hemispheres of SHR and
WKY (Figure 5D). This ﬁnding was further corroborated by the
qRT-PCR analysis of the typical M1 markers IL-1β, IL-6, and
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FIGURE 3 | Adhesion molecule expression on brain endothelial cells and infiltrated CD45 high leukocytes was determined by flow cytometry.
(A) Gating strategy to differentiate CD31+ endothelial cells (1) from CD11b+ myeloid leukocytes (3) in whole hemispheric lysates. Measurement of median
fluorescence intensities (MFIs) of (B) intercellular adhesion molecule 1 (ICAM-1), (C) vascular cell adhesion molecule 1 (VCAM-1) and (D) P-selectin (CD62P) on
surfaces of endothelial cells and myeloid leukocytes in brains of SHRs and WKYs; n = 3/3/4/6, data are mean values ± standard deviation. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001. AFCO, autofluorescence control; ipsi, ipsilateral; contra, contralateral.
TNF-α as well asM2markers IL-10,MMP9, and TGF-β (Courties
et al., 2014), which were comparable between SHR and WKY
after stroke (Figure 6). Together, our ﬁndings provide evidence
that arterial hypertension strongly augments the innate immune
response to stroke, but has no impact onmacrophage polarization
within the ischemic lesion.
DISCUSSION
For decades, stroke has been considered a strictly localized
neurological disease with a loss of neural tissue entailing
classical stroke-related symptoms. However, ischemic tissue
damage always causes a sterile inﬂammatory response that is
indispensable for controlling brain repair and regeneration,
but also strongly contributes to secondary damage and
functional deterioration (Iadecola and Anrather, 2011;
Gelderblom et al., 2012; Shichita et al., 2012a; Neumann
et al., 2015).
In the present study, the infarct volume was comparable
between WKY and SHR at day 1, but signiﬁcantly higher in
SHR 3 days after PT. The ﬁnal lesion size in this stroke model
is reached 4 h after ischemia onset (Grome et al., 1988), thus later
changes may be attributed to the brain water content, delayed
cell death or secondary inﬂammatory mechanisms (Witte and
Stoll, 1997; Carmichael, 2005; Shichita et al., 2012b). Brain edema
developed comparably in WKY and SHR, but the infarct volume
strongly correlated with the amount of CD45 highly positive
leukocytes in the ischemic hemisphere.
As described previously (Gronberg et al., 2013; Lehmann et al.,
2014; Moller et al., 2014) and in accordance with prototypic
models of sterile inﬂammation (Bratton and Henson, 2011),
the early inﬂammatory inﬁltrate primarily consisted of PMNs,
monocytes, and macrophages whereas T- and B cell counts were
not changed 4 days after stroke. Short-lived PMNs constitute
the ﬁrst wave of immune cells that invade into the ischemic
brain, where they strongly contribute to brain damage (Akopov
et al., 1996; Price et al., 2004; Gelderblom et al., 2012; Jickling
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FIGURE 4 | mRNA expression of the CC chemokine ligands 2 (CCL2), 3
(CCL3), 4 (CCL4), 7 (CCL7) and of the CXC chemokine ligands 2
(CXCL2) and 5 (CXCL5) in whole hemispheric lysates of SHRs and
WKYs. n = 3/3/3/3, data are mean values ± standard deviation. ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
et al., 2015; Neumann et al., 2015). In fact, increased PMN
inﬁltration could be one conclusive explanation for the larger
infarct sizes in SHR. Apoptotic neutrophils are phagocytosed by
monocytes and macrophages which is, in turn, an important
impulse for the resolution of necrotic tissue and the initiation
of macrophage repair and regeneration programs (Chu et al.,
2015; Headland and Norling, 2015; Ritzel et al., 2015). SHR
exhibited signiﬁcantly higher monocyte and macrophage counts
in the ischemic hemisphere, which might be a consequence of
the preceding increase of neutrophil inﬁltration. The relative
shift toward macrophages (Resolution Index, Figure 5C) in
SHR might argue for an accelerated resolution of inﬂammation
in hypertensives, but this ﬁnding was not supported by the
investigation of M1/M2 macrophage polarization markers which
were comparable between WKY and SHR. Future studies
focusing on eﬀerocytosis as the key event of inﬂammation
resolution in SHR and normotensive controls are needed to
clarify this issue.
The correct timing and balance between protective and
detrimental inﬂammation is regulated by four major categories
of mechanisms: (1) the amount and activation state of circulating
immune cells and their successive replenishment from bone
marrow and spleen (Leuschner et al., 2012; Courties et al., 2015);
FIGURE 5 | Differentiation and quantification of leukocyte subsets in the brain of SHRs and WKYs subjected to photothrombotic stroke. (A) Gating
strategy to assess CD45 high positive leukocytes, T cells, B cells, polymorphonuclear granulocytes (PMN), monocytes, macrophages and CD11b+ dendritic cells in
whole hemispheric lysates. (B) Absolute cell counts of the aforementioned leukocytes subsets were determined by Trucount measurements. (C) The resolution index
was calculated by dividing the PMN count through the macrophage count. (D) M1 or M2 macrophage polarization was determined by macrophage expression of
CD80 or CD163, respectively; n = 3/3/5/8, data are mean values ± standard deviation. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. DC, dendritic cells; ipsi, ipsilateral;
contra, contralateral.
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FIGURE 6 | mRNA expression of representative M1 (IL-1β, IL-6, and
TNF-α) and M2 (IL-10, MMP9, and TGF-β) macrophage markers in
whole hemispheric lysates of SHRs and WKYs; n = 3/3/3/3, data are
mean values ± standard deviation. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Scale bars: (A) 200 μm; (B) 20 μm.
(2) Chemoattractants secreted by parenchymal and endothelial
cells of the ischemic brain (Mirabelli-Badenier et al., 2011); (3)
AM expression on cerebral capillaries and post-capillary venules
(Yilmaz and Granger, 2008); (4) The environmental cues within
the ischemic brain tissue that adjust and conﬁne successive
immune responses (Iadecola and Anrather, 2011; Hu et al., 2012).
Cumulating evidence suggests that hypertension aﬀects at least
some of the aforementioned mechanisms and may thus increase
detrimental neuroinﬂammation and aggravate stroke severity.
An impaired autonomic response is one unifying symptom
of neurogenic hypertension in SHR and patients (Mancia and
Grassi, 2014; Zubcevic et al., 2014). Increased adrenergic output,
e.g., by arterial hypertension has been shown to have a direct
eﬀect on the bone marrow hematopoietic niche resulting in
increased levels of monocytes and neutrophils in the circulation
(Heidt et al., 2014; Zubcevic et al., 2014). In fact, this
and previous studies (Schmid-Schonbein et al., 1991) showed
increased monocyte and neutrophil counts in the blood of naive
SHR, which may eventually contribute to increased immune
cell inﬁltration and infarct expansion in the ischemic brain.
Compatible with this, a strong positive correlation between
circulating neutrophils and infarct volume has been described in
stroke patients (Buck et al., 2008).
In hypertensives, the brain microvasculature is subjected to a
continuous pulsatile barotrauma which causes the remodeling of
the vessel walls and endothelial dysfunction (Wang et al., 2004;
Scuteri et al., 2011; Yannoutsos et al., 2014). Increased expression
of AMs and chemokines are hallmarks of endothelial activation
(Tummala et al., 1999; Schober and Zernecke, 2007; Liao, 2013)
promoting recruitment of circulating immune cells into the
brain (Ley et al., 2007). Patients with arterial hypertension and
cerebral small vessel disease showed increased levels of both
soluble selectins (CD62P and CD62E) and integrins (ICAM-
1 and VCAM-1; Sanada et al., 2005; Shalia et al., 2009; Rouhl
et al., 2012) which can be considered as surrogates for their
endothelial expression (Zonneveld et al., 2014). We recently
found that VCAM-1 expression was signiﬁcantly increased in
cerebral endothelial cells of middle-aged SHR (Kaiser et al.,
2014). We therefore hypothesized that increased endothelial AM
expression due to hypertension may augment leukocyte adhesion
and transmigration after stroke. However, in this study, we
did not observe increased AM expression in endothelial cells
of naive SHR possibly due to their relatively young age (12–
14 weeks). By contrast, we found signiﬁcantly lower endothelial
CD62P expression in SHR which may be a consequence of
enhanced proteolytic cleavage by circulating metalloproteinases
(Chen et al., 2012). PT induced a strong upregulation of CD62P
expression in bothWKY and SHR, but this was neither attributed
to endothelial cells nor inﬁltrating immune cells. Alternatively,
immunohistochemistry revealed diﬀuse extracellular CD62P
expression within the infarction which may represent platelets
(Yang et al., 2009) crosslinking inﬁltrating leukocytes (Franks
et al., 2010; Mezger et al., 2015).
Similar to CD62P, ICAM-1 expression was signiﬁcantly
increased in ischemic hemispheres of WKY and, even more,
SHR. Flow cytometry further speciﬁed an upregulation of
ICAM-1 on inﬁltrating myeloid cells of SHR. In contrast,
ICAM-1 expression on endothelial cells was not changed
4 days after stroke, possibly because responsive endothelial
AM expression peaks earlier (Jander et al., 1995; Yilmaz
and Granger, 2008). Leukocytic ICAM-1 expression occurs
primarily on monocytes/macrophages and enhances endothelial
transmigration by homotypic leukocyte–leukocyte interactions
(Goebeler et al., 1993; Meisel et al., 1998; Ruetten et al.,
1999; Steidl et al., 2000; Novosad et al., 2011). ICAM-1
expression on antigen presenting cells may further act as an
important costimulatory signal for T cell activation at the
site of inﬂammation (Goebeler et al., 1993; Real et al., 2004).
The fact that leukocytes also express functionally relevant
ICAM-1 provides novel approaches to interpret ﬁndings from
stroke studies using ICAM-1 antibodies or ICAM-1 knock-
out animals (Connolly et al., 1996; Enlimomab Acute Stroke
Trial Investigators, 2001). At the moment, we do not have
a conclusive explanation for the increased levels of ICAM-1
on myeloid immune cells of SHR. One could speculate that
the known pro-inﬂammatory state in hypertensives increases
leukocyte ICAM-1 expression and thus contributes to increased
post-stroke inﬂammation, but this assumption warrants further
investigations.
Leukocyte traﬃcking into the ischemic brain is regulated by
various chemokines that attract leukocytes toward the aﬀected
vasculature and support AM-regulated leukocyte transmigration
(Ley et al., 2007). Most of the inﬂammatory chemokines were
found to be upregulated after stroke and are secreted either by
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brain resident astrocytes, neurons, microglia, endothelial cells,
or by inﬁltrating leukocytes (Mirabelli-Badenier et al., 2011).
The relevance of post-stroke chemokine secretion has been
recently underpinned by a study showing that the neutralization
of circulating chemokines using a broad spectrum chemokine
binding protein caused a signiﬁcant reduction of leukocytes
inﬁltrating the ischemic brain (Lee et al., 2015). In this study, PT
induced a strong increase of chemokines that attract monocytes
(CCL2, CCL3, CCL4, and CCL7) and neutrophils (CXCL2),
whereas T cell-attracting chemokines (CCL19, CCL20) were
not altered. This pattern adequately reﬂects the composition
of the ischemic brain inﬁltrate at this time point, as discussed
above. While the expression levels in naive animals did not
diﬀer, CCL2, CCL7, and CXCL2 expression was signiﬁcantly
ampliﬁed in SHR after stroke. This could be interpreted as both,
a cause or consequence of increased leukocyte inﬁltration in
SHR. Interestingly, we observed a contrary ﬁnding for CCL3
that was expressed at signiﬁcantly higher levels in ischemic
hemispheres of WKY. It has been reported in experimental
autoimmune encephalomyelitis thatmononuclear cell inﬁltration
in the acute disease and the relapse phase is controlled by
CCL3 or CCL2, respectively (Kennedy et al., 1998), suggesting
a distinct functional diﬀerentiation of both chemokines. This
idea is further corroborated by the recent ﬁnding that CCL3
deﬁciency strongly increases inﬂammatory cell inﬁltration after
experimental traumatic brain injury (Israelsson et al., 2014).
We therefore hypothesized that the unexpected decrease of
CCL3 expression in SHR could be attributed to the accelerated
resolution of inﬂammation as corroborated by an increased
resolution index (Figure 5C).
Our study has limitations. The use of SHR and WKY rat
strains may be confounded by genetic diﬀerences apart from
or primary to hypertension (Zhang-James et al., 2013). Thus,
it is diﬃcult to clearly diﬀerentiate between pathophysiological
changes due to the hypertensive state or other unknown
phenotypes. One example is the tight junction and adhesion
molecule (JAM-1) which is already increased in brains of
pre-hypertensive SHR and contributes to the development of
hypertension. On the other hand, it also mediates leukocyte
adhesion and platelet aggregation and may thus contribute to
the course of post-stroke inﬂammation (Waki et al., 2007).
Moreover, we focused our analyses on peripheral CD45 highly
positive leukocytes even though microglia and astrocytes also
signiﬁcantly contribute to stroke pathophysiology and may
be functionally altered by arterial hypertension (Marks et al.,
2001; Yamagata, 2012). Immune cell depletion studies would be
necessary to separate the pathophysiological relevance of certain
immune cell subsets from brain-resident cells under hypertensive
conditions. The study is ﬁnally limited by a relatively small
sample size that may have caused Type II errors especially
in the behavioral tests that empirically underlie increased
variability.
In summary, we observed that pre-existing hypertension
caused larger stroke sizes possibly as consequence of a profound
increase of post-stroke inﬂammation. This ﬁnding could be
explained by increased numbers and activation status of
circulating myeloid leukocytes and increased levels of leukocyte-
attracting chemokines in hypertensives. Future translational
stroke research should consider the immunological eﬀects of the
frequent co-morbidity hypertension, especially when targeting
the immune response to stroke.
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